Loading stock data…
$0.83+0.01 (+1.16%)
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel.
PRF Technologies Ltd. in the Healthcare sector is trading at $0.83 with a market capitalization of $1M. The stock is currently near its 52-week low of $0.81, remaining 58.8% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 17 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q4 2025 | Q2 2025 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | -$7.34M↓ | -$5.57M↓ | -$3.56M |
| Net Income | — | — | -$7.31M↓ | -$5.51M↓ | -$4.89M |
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in catarac...